Randomized Trial in Advanced Ovarian Cancer Comparing Cisplatin and Carboplatin
The aim of this multicenter randomized trial was to compare carboplatin (400 mg/m2) and cisplatin (100 mg/m2) in patients with untreated advanced epithelial ovarian cancer. Toxi...